A Randomised Double-blind, Placebo-controlled, Phase 1b Trial to Evaluate the Safety, Tolerability and Protective Efficacy of the Influenza Vaccine Candidate, FLU-v, in an Influenza Challenge Model.
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2015
At a glance
- Drugs FLU-v (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors SEEK
- 08 Dec 2010 Status changed from active, no longer recruiting to completed according to a SEEK media release.
- 08 Dec 2010 Results from this trial are expected in early 2011, according to a SEEK media release.
- 28 Oct 2010 New trial record